Can offering addiction treatment in liver clinics help patients quit alcohol?

NCT ID NCT06493773

Recruiting now Disease control Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether offering specialized alcohol use disorder treatment right in the liver clinic helps people newly diagnosed with alcohol-related liver disease stop drinking. About 221 participants will either get this offer plus standard care, or standard care alone. The main goal is to see if more people stay alcohol-free for at least 30 days after 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: specialized alcohol use disorder treatment (behavioral and medical)
What this could lead to: If successful, this approach could become a standard way to help people with alcohol-related liver disease stop drinking and improve their liver health.
What could go wrong: This is a relatively small, early-stage trial. The treatment may not work for everyone, and some patients may not stick with it. Results may not apply to all liver disease patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse alcoholic liver disease liver disorder Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER ALCOHOLISM LIVER DISEASE; ALCOHOL-RELATED LIVER DISEASES, ALCOHOLIC TREATMENT ADHERENCE

Contacts and locations

Locations

Department of Medicine, Zealand University Hospital
RECRUITING

Køge, Køge, 4600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.